Impact of behavioral side effects on the management of Parkinson patients treated with dopamine agonists
Dopamine agonists are one of the main stay of treatment option for Parkinson disease (PD). Side effects that develop from their use are generally categorized into behavioral and non-behavioral. Behavioral side effects include: impulse control behavior disorder (ICD), psychosis and cognitive impairme...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Clinical Parkinsonism & Related Disorders |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590112521000037 |